Literature DB >> 13472044

TOXOPLASMIC uveitis and pyrimethamine.

.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/therapeutic use; TOXOPLASMOSIS/manifestations; UVEITIS/etiology and pathogenesis

Mesh:

Substances:

Year:  1957        PMID: 13472044      PMCID: PMC1962697     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  19 in total

1.  Studies on the aetiological problem of uveitis.

Authors:  C SMITH; N ASHTON
Journal:  Br J Ophthalmol       Date:  1955-09       Impact factor: 4.638

2.  The laboratory diagnosis of toxoplasmosis.

Authors:  I A CATHIE
Journal:  Proc R Soc Med       Date:  1955-12

3.  [Treatment of experimental toxoplasmosis in white mice with plaquenil, daraprim and fumagillin].

Authors:  A TREVINO; G VARELA; L PALENCIA
Journal:  Rev Inst Salubr Enferm Trop       Date:  1953-12

4.  Toxoplasma adenopathy in a child with isolation of the parasite.

Authors:  I A CATHIE
Journal:  Lancet       Date:  1954-07-17       Impact factor: 79.321

5.  Acquired toxoplasmosis; with a report of two cases simulating glandular fever and one possible case resembling typhus.

Authors:  E SKIPPER; J K BEVERLEY; C P BEATTIE
Journal:  Lancet       Date:  1954-02-06       Impact factor: 79.321

6.  A study of the role of toxoplasmosis in adult chorioretinitis.

Authors:  A C WOODS; L JACOBS; R M WOOD; M K COOK
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1954 Mar-Apr

7.  Toxoplasmosis found by recovery of toxoplasma gondii from excised maxillary gland.

Authors:  C ARMSTRONG; F G MACMURRAY
Journal:  J Am Med Assoc       Date:  1953-03-28

8.  Toxoplasmosis in the adult.

Authors:  S DUKE-ELDER; N ASHTON; M BRIHAYEVAN GEERTRUYDEN
Journal:  Br J Ophthalmol       Date:  1953-06       Impact factor: 4.638

9.  Adult ocular toxoplasmosis; a preliminary report of a parasitologically proved case.

Authors:  L JACOBS; J R FAIR; J H BICKERTON
Journal:  AMA Arch Ophthalmol       Date:  1954-03

10.  The chemotherapeutic efficacy of 2,4-diamino-5-p-chlorophenyl-6-ethylpyrimidine (daraprim) in experimental toxoplasmosis.

Authors:  W A SUMMERS
Journal:  Am J Trop Med Hyg       Date:  1953-11       Impact factor: 2.345

View more
  2 in total

Review 1.  Drug repurposing for the treatment of staphylococcal infections.

Authors:  Shankar Thangamani; Haroon Mohammad; Waleed Younis; Mohamed N Seleem
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  Drug repurposing and human parasitic protozoan diseases.

Authors:  Katherine T Andrews; Gillian Fisher; Tina S Skinner-Adams
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-03-24       Impact factor: 4.077

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.